Does TADALAFIL Cause Application site erythema? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Application site erythema have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.0% of all adverse event reports for TADALAFIL.
6
Reports of Application site erythema with TADALAFIL
0.0%
of all TADALAFIL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Application site erythema From TADALAFIL?
Of the 6 reports, 2 (33.3%) required hospitalization.
Is Application site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Application site erythema?
NICOTINE (2,004)
SUMATRIPTAN (1,875)
INGENOL MEBUTATE (1,373)
BUPRENORPHINE (1,273)
ESTRADIOL (1,117)
MINOXIDIL (1,061)
METHYLPHENIDATE (543)
ESTRADIOL\NORETHINDRONE (533)
FENTANYL (501)
OXYTROL FOR WOMEN (422)
Which TADALAFIL Alternatives Have Lower Application site erythema Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR